WORLD IN A DAY · TUESDAY, NOVEMBER 17, 2026
A boardroom decision at the world’s most valuable chipmaker rattled Wall Street on the same day diplomats in Antalya and The Hague’s near neighbors kept grinding through unfinished fights over climate money and a war that will not pause for talks.
Nvidia Board Rules Out Jensen Huang’s Return as Wall Street Slides Again
Nvidia’s board told investors it is not considering bringing Jensen Huang back as chief executive, five days after his resignation, and is instead vetting outside successors even as Elon Musk, Donald Trump and parts of Silicon Valley lobby for his reinstatement. Interim CEO Colette Kress is steering the company through the transition. The news compounded a rough session on Wall Street: the Dow fell more than 700 points to close near 51,600, the Nasdaq dropped about 2.5 percent and the S&P 500 lost roughly 1.9 percent, as traders grew anxious ahead of Nvidia’s upcoming earnings and Anthropic’s IPO.
Why it matters A leadership vacuum at the world’s most valuable chipmaker, arriving just as two of the market’s biggest catalysts loom, is testing how much of the AI trade was priced on one executive’s credibility rather than the technology itself.
Source: Business Standard
Russian Missiles Hit Two Kyiv Bridges as Ukraine Claims Crimean Bridge Strike
Russian missiles struck two major bridges in Kyiv on Tuesday, Mayor Vitali Klitschko said, disrupting traffic and further straining the capital’s war battered infrastructure. Separately, Ukraine’s military said it damaged the Kerch Strait Bridge linking Russia to occupied Crimea in a retaliatory strike; Russian officials disputed the claim, saying the attack was intercepted. Rockets also killed at least three people in northeastern Ukraine, officials said. The exchange came as Kyiv presses Washington and European allies for security guarantees rather than NATO membership in exchange for any territorial concession in the Donbas.
Why it matters Each side’s competing damage claims are their own front in this war, and the strikes show neither Moscow nor Kyiv is slowing its attacks while diplomats negotiate a settlement.
Source: PBS NewsHour / AP
Update: First Draft of COP31 Deal Leaves Fossil Fuels and Climate Finance Unresolved
Negotiators in Antalya released the first full draft text of a COP31 agreement, and it left the summit’s two hardest fights, a timeline for moving away from fossil fuels and how to close the climate finance gap, largely unresolved. The draft arrives as COP31 enters its final, decisive week, a day after UN Secretary General Antonio Guterres warned financing could fall 840 billion dollars short of what developing nations need. Negotiators from major blocs called the text a starting point rather than a breakthrough, with fights still ahead over adaptation finance targets and whether to reference a fossil fuel transition roadmap at all.
Why it matters A weak starting draft this late in the conference raises the odds COP31 ends, like COP30 before it, by deferring the fossil fuel question to next year’s summit.
Source: Rappler
Supreme Court Leaves $59 Million in UC Research Funding Intact, Rejects Trump Bid
The US Supreme Court turned away the Trump administration’s emergency bid to cut 59 million dollars in University of California research grants that were flagged and terminated using DEI related keyword searches, leaving a Ninth Circuit order reinstating the funding in place. The case, Trump v. Thakur, is one of several challenges to the administration’s cancellation of federal research money over DEI and environmental justice language; the White House has acknowledged using keyword searches across grant descriptions to identify funding to cut. The underlying lawsuit continues in lower courts.
Why it matters The order does not decide whether keyword based DEI screening can be used to cancel research funding more broadly, but it keeps federal money flowing to UC labs for now and signals the justices are not ready to let the fight skip a full appeals review.
Source: NBC News
FDA Approves Novartis’s Cosentyx as First Biologic for Polymyalgia Rheumatica
The FDA approved Novartis’s Cosentyx, known generically as secukinumab, for polymyalgia rheumatica, making it the first and only anti IL17 biologic approved for the inflammatory condition, which causes aching and stiffness in the shoulders, neck and hips, mostly in adults over 65. Novartis said Cosentyx met its main and secondary goals in a Phase III trial, reducing flares and letting more patients taper off steroids, the current first line treatment, which carries long term risks including bone loss and diabetes. The approval follows a similar European Commission clearance for Cosentyx in PMR.
Why it matters Steroids have been the only real option for PMR for decades despite their side effects, so a biologic alternative changes the calculus for an often overlooked disease that mostly affects older adults.
Source: Novartis / GlobeNewswire
Europe’s Euclid Telescope Unexpectedly Discovers Its First Comet
The European Space Agency’s Euclid space telescope, built to map dark matter and dark energy, unexpectedly discovered its first comet, designated C/2026 S1 (Euclid), while scanning the sky roughly 810 million miles from Earth. Researchers spotted the object’s faint, moving trail in routine calibration images and confirmed it was a previously unknown comet rather than an instrument artifact. ESA said the find shows the mission’s wide, deep imaging can catch objects far outside its primary science goals, and follow up observations are being used to refine the comet’s orbit and composition.
Why it matters A cosmology telescope stumbling onto a new comet is a reminder that the biggest survey instruments often deliver their most memorable discoveries by accident, not by design.
Source: European Space Agency
Sources
- Business Standard: Nvidia board not considering Jensen Huang’s return as CEO
- BBN Times: Dow Jones falls to 51,608.17 as Nvidia fallout and bank weakness hit blue chips
- PBS NewsHour / AP: Russian rockets kill 3 in northeastern Ukraine as Kyiv claims it damaged Crimean bridge
- The Kyiv Independent: Ukrainian forces reportedly strike Crimean Bridge after Russian missiles hit Kyiv bridges
- Rappler: First draft of COP31 deal signals tough negotiations to come
- NBC News: Supreme Court rejects Trump academic funding cuts tied to DEI
- Novartis / GlobeNewswire: Cosentyx becomes first and only FDA-approved anti-IL-17 biologic for PMR
- European Space Agency: Euclid discovers new comet
More in Education
